Brief: Ekso Bionics Holdings Reports Q2 Loss Per Share $1.88
July 30 (Reuters) - Ekso Bionics Holdings Inc EKSO.O :
* EKSO BIONICS REPORTS SECOND QUARTER 2020 RESULTS
* Q2 LOSS PER SHARE $1.88
* Q2 REVENUE $2.3 MILLION VERSUS $3.3 MILLION
Source text for Eikon: ID:nGNX9qbS8d
Further company coverage: EKSO.O
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Chronoscale
See all newsBrief: Chronoscale To Divest Ekso Bionics And Focus On Cloud Business
Brief: Applied Digital Completes Separation Of Cloud Business, Establishing Chronoscale As Independent Public Company
Brief: Ekso Bionics Holdings On Feb 15, Enters Agreement With Apld Intermediate
Applied Digital jumps after Q2 revenue beats on AI data center demand
Applied Digital beats quarterly revenue estimates on AI data center demand, shares jump